Mark Packer MD, Chief Medical Officer will highlight Cassini as core technology in today’s refractive cataract surgery ecosystem. Cassini enables seamless integration of clinic and operating suite, from preoperative diagnostics through visualization and laser applications to postoperative analysis. Cassini data demonstrate 94.0% reduction of astigmatism to target, 0.50 Diopter or less. These results help increase the adoption of premium cataract surgery and Advanced Technology IOL’s.
Cassini appears to offer very high specificity in estimating corneal keratometry and specific corneal irregularity indices, even in topographically challenging corneas such as LASIK treated, keratoconic, and cross-linked.